| Dr Virginia Carol Fiedler, MD | |
|
1921 Lake Ave, Suite C, Wilmette, IL 60091-1480 | |
| (847) 920-1700 | |
| (847) 920-1739 |
| Full Name | Dr Virginia Carol Fiedler |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 1921 Lake Ave, Wilmette, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184749061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301052338 (Michigan) | Secondary |
| 207N00000X | Dermatology | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Virginia Carol Fiedler, MD 1921 Lake Ave, Suite C, Wilmette, IL 60091-1480 Ph: (847) 920-1700 | Dr Virginia Carol Fiedler, MD 1921 Lake Ave, Suite C, Wilmette, IL 60091-1480 Ph: (847) 920-1700 |
News Archive
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, will offer attendees of PITTCON 2010 an in-depth perspective on advances in analytical instrumentation, laboratory services, and consumables for the environmental, pharmaceutical/nutraceutical and academic markets.
A team of scientists at Karolinska Institutet and Harvard University has taken a major step towards treatment for heart attack, by instructing the injured heart in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.
A new study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9 percent decrease in body weight three months after the procedure. Results of the study, which offer a potential new avenue for obesity research, will be presented next week at the annual meeting of the Radiological Society of North America.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
In a startling new study that involved research on both sides of the Atlantic, scientists from The Scripps Research Institute in Florida and the University College London Institute of Neurology in England have shown for the first time that abnormal prions, bits of infectious protein devoid of DNA or RNA that can cause fatal neurodegenerative disease, can suddenly erupt from healthy brain tissue.
› Verified 9 days ago
Liborka Kos, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3232 Lake Ave, Wilmette, IL 60091 Phone: 847-318-9330 | |
Dr. Cecelia H. Ricketts, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 401 Linden Ave, Wilmette, IL 60091 Phone: 847-920-9177 Fax: 847-920-9188 | |
Dr. Gerta S Janss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 711 11th St, Wilmette, IL 60091 Phone: 847-920-0225 |